Springworks Therapeutics (SWTX) shares rose past 34% in recent Monday trading after Reuters reported that Germany's Merck KGaA is in advanced talks to acquire the company.
A deal could be signed in the coming weeks if the talks are successful, the report said earlier Monday, citing unnamed people familiar with the matter.
The sources added that although discussions between the companies have advanced, there is still a possibility that another potential buyer for Springworks could come forward.
Springworks declined to comment when contacted by MT Newswires.
Price: 54.58, Change: +14.30, Percent Change: +35.50
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.